-- Galderma Seeking Biotechnology and Pharmaceutical Partnerships in
Dermatology --
PARIS and FORT WORTH, Texas, April 5 /PRNewswire/ -- Galderma
International S.A. today announced that Arthur Clapp, Vice President,
Business Development at Galderma Laboratories, L.P., will present an
overview of Galderma and the Company's biotechnology and pharmaceutical
partnering initiatives at the upcoming BIO 2006 Annual International
Convention which is being held at the McCormick Place Convention Center,
Chicago, Ill., April 9-12, 2006. The presentation will take place in the
conference Business Forum on Wednesday, April 12, 2006 at 9:00 a.m. central
time. In addition to the Company presentation, Galderma will have five
representatives participating in one-on-one partnering meetings in the BIO
2006 Business Forum.
The company's growing product portfolio includes treatment for major
skin conditions -- acne, rosacea, fungal nail infections, psoriasis,
non-melanoma skin cancer and photodamage, and hyperpigmentation disorders.
Galderma is actively seeking to establish in-licensing or co-development
partnerships with biotechnology and pharmaceutical companies.
Galderma's partnered products, programs and discovery technologies are
supported by global product development capabilities and a world renowned
sales force of over 900 representatives in more than 65 countries. Galderma
has a history of successful transactions that have resulted in the creation
of numerous commercialized prescription products including Metvix(R),
Clobex(R), Clindagel(R), Loceryl(R), Tri-Luma(R), Silkis(R), and
MetroGel(R)/Rozex(R).
Partnering Opportunities:
Galderma understands what it takes to build and nurture successful
relationships. Galderma is interested in reviewing products that have a
known mechanism of action with both profiled safety and some proof of
concept in humans. Products can either be topical or systemic; small
molecules or biologics; or even a medical device or delivery platform.
Galderma's research teams are also looking for novel compound libraries,
assays, in vivo models, and disease targets.
About Galderma:
Galderma is one of the world's leading specialty pharmaceutical
companies, focused exclusively on research, development and marketing of
dermatology products. The company deploys a worldwide network of 33 fully
owned subsidiaries with products marketed in more than 70 countries.
Galderma International S.A. is headquartered in Paris, France and Galderma
Laboratories, L.P., the United States subsidiary of Galderma Pharma S.A.,
is headquartered in Fort Worth, Texas.
For partnering inquiries, please contact:
Chris de Bruyne Arthur Clapp
Galderma International S.A. Galderma Laboratories L.P.
Paris, France Fort Worth, Texas
+33-1-5886-4375 +1 (817) 961-5005
SOURCE Galderma
 back to top
CONTACT:
Chris de Bruyne of Galderma International
S.A., +33-1-5886-4375; or Arthur Clapp of Galderma Laboratories
L.P., +1-817-961-5005
|
